Speaker illustration

Assistant Professor Ana Palanca

University of Cantabria, Santander (Spain)

Newly experimental designed CTPR390-488 biosynthetic nanoparticle as a potential biomarker-drug of myocardial fibrosis

Event: Frontiers in CardioVascular Biology 2018

Topic: Fibrosis

Session: Basic Science - Cardiac Diseases

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb